期刊文献+

Isolation and Characterization of Exosomes Derived from Tumor Cells Genetically Expressing Model Antigen 被引量:4

Isolation and Characterization of Exosomes Derived from Tumor Cells Genetically Expressing Model Antigen
下载PDF
导出
摘要 Tumor cell-derived exosomes have been proposed as non-cellular nanomeric vaccine which could induce potent anti- tumor immune response in mice. In order to develop the protocols to prepare tumor cell-derived exosomes for basic research and clinical trail, we isolated exosomes from ovalbumin (OVA)-expressing thymoma cells EG.7-OVA by various preparation methods. We demonstrate the non-sedimentation method is simple, rapid, efficient with higher yield and purity of exosomes. EG.7-OVA-derived exosomes are 40-100 nm in diameter sequestered by lipid bi-layer, and contain rich heat shock protein (HSP) and OVA. The result of the size distribution determination is consistent with the calculation by the visual microscopic inspection, with 90.4% particles at the range of 50-90 nm. Moreover, as a model antigen of the EG.7 cells, OVA concentra- tion in EG.7-derived exosomes can be regarded as a good quality control parameter. Therefore, we have established a platform to efficiently prepare exosomes for tumor immunotherapy. Tumor cell-derived exosomes have been proposed as non-cellular nanomeric vaccine which could induce potent anti- tumor immune response in mice. In order to develop the protocols to prepare tumor cell-derived exosomes for basic research and clinical trail, we isolated exosomes from ovalbumin (OVA)-expressing thymoma cells EG.7-OVA by various preparation methods. We demonstrate the non-sedimentation method is simple, rapid, efficient with higher yield and purity of exosomes. EG.7-OVA-derived exosomes are 40-100 nm in diameter sequestered by lipid bi-layer, and contain rich heat shock protein (HSP) and OVA. The result of the size distribution determination is consistent with the calculation by the visual microscopic inspection, with 90.4% particles at the range of 50-90 nm. Moreover, as a model antigen of the EG.7 cells, OVA concentra- tion in EG.7-derived exosomes can be regarded as a good quality control parameter. Therefore, we have established a platform to efficiently prepare exosomes for tumor immunotherapy.
出处 《Journal of Microbiology and Immunology》 2004年第4期278-285,共8页 中华微生物学和免疫学(英文版)
关键词 肿瘤细胞 外来体 模型抗原 遗传因素 基因表达 Exosomes Tumor cells Heat shock proteins Antigen
  • 相关文献

同被引文献13

  • 1牟丹蕾,贾战生,白雪帆.胞外体——免疫治疗中的“特洛伊木马”[J].生理科学进展,2005,36(2):113-118. 被引量:4
  • 2修方明,曹雪涛.Exosomes in the Immune Response and Tolerance[J].Journal of Microbiology and Immunology,2004,2(4):231-236. 被引量:3
  • 3杜英,陈绍倩,黄玉敏,董子明.人脐血树突状细胞分泌外来体的特性及其增强CTL杀伤活性的研究[J].细胞与分子免疫学杂志,2006,22(1):33-36. 被引量:3
  • 4Lamparski HG, Metha-Damani A, Yao JY, et al. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods, 2002, 270:211-226.
  • 5Andre F, Schartz NE, Movassagh M, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet, 2002, 360 : 295 -305.
  • 6Wolfers J, Lozier A, Raposo G, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL crosspriming. Nat Med, 2001,7:297-303.
  • 7Gastpar R, Gehrmann M, Bausero MA, et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res, 2005, 65: 5238-5247.
  • 8Morelli AE, Larregina AT, Shufesky WJ, et al. Endocytosis, intraceular sorting, and processing of exosomes by dendritic cells. Blood, 2004, 104:3257-3266.
  • 9van den Broke LT, Daschbach E, Thomas EK, et al. Dendritic cell-induced activation of adaptive and innate antitumor immunity. J Immunol, 2003, 171:5842-5852.
  • 10Rotem D, Cassel A, Lindenfeld N, et al. Urinary cytokeratin 20 as a marker for transitional cell carcinoma. Eur Urol, 2000, 37 : 601-604.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部